List view / Grid view
8 August 2018 | By Mike Stones
Cardiac monitoring of high-risk breast cancer patients should be prioritised, after research revealed low rates of heart monitoring seen in the patients receiving trastuzumab.
6 August 2018 | By Mike Stones
Senescent, or zombie cells, are being targeted with the development of a new nanocarrier drug delivery system.
20 July 2018 | By Iqra Farooq (European Pharmaceutical Review)
The onset of side effects of a common cancer treatment, anti-PD-1 therapy can be identified up to 3 years after treatment...
2 July 2018 | By European Pharmaceutical Review
Testing could lead to extension of life through improved clinical decision-making by identifying patients who need to switch from targeted hormonal therapy to chemotherapy...
28 June 2018 | By European Pharmaceutical Review
A combination of mTOR inhibitors and Phenformin leads to an increase in overall survival...
13 June 2018 | By European Pharmaceutical Review
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
31 May 2018 | By European Pharmaceutical Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
24 May 2018 | By European Pharmaceutical Review
Researchers hope immunotherapy will prevent against overactive immune response...
18 May 2018 | By European Pharmaceutical Review
Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.
15 May 2018 | By European Pharmaceutical Review
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
1 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice...
25 April 2018 | By European Pharmaceutical Review
A novel technique called radiation segmentectomy (RS), that delivers high doses of radiation to tumours while sparing the surrounding healthy tissue, shows promise as a curative treatment option for patients with early-stage liver cancer, according to a recent study.
25 April 2018 | By European Pharmaceutical Review
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma...
24 April 2018 | By European Pharmaceutical Review
Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients.
20 April 2018 | By European Pharmaceutical Review
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects...
Send this to a friend
Follow: